C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/259, 260/300
C07D 239/28 (2006.01) C07D 213/73 (2006.01) C07D 213/75 (2006.01) C07D 231/16 (2006.01) C07D 231/40 (2006.01) C07D 239/42 (2006.01) C07D 239/46 (2006.01) C07D 239/545 (2006.01) C07D 249/04 (2006.01) C07D 249/08 (2006.01) C07D 249/14 (2006.01) C07D 257/06 (2006.01) C07D 403/02 (2006.01)
Patent
CA 1200549
ABSTRACT HETEROCYCLIC DERIVATIVES This invention relates to heterocyclic derivatives which are histamine H-2 antagonists and which inhibit gastric acid secretion. According to the invention there is provided a guanidine derivative of the formula I:- Image in which R1 and R2, same or different, are hydrogen or 1-10C alkyl, 3-8C cycloalkyl, 4-14C cycloalkylalkyl, each alkyl, cycloalkyl or cycloalkylalkyl optionally carrying one or more F, Cl or Br atoms, provided that one of R1 and R2 is halogen-substituted, or R2 is hydrogen and R1 is R5-E-W- in which W is 2-6 alkylene optionally substituted by 1or2 1-4C alkyls, E is O,S,SO,SO2 or NR6 in which R6 is H or 1-6C alkyl, R5 is H or 1-6C alkyl optionally substituted by 1 or 2 1-4C alkyls, or R5 and R6 are joined to form a pyrrolidine, piperidine, morpholine, piperazine or N-methylpiperazine ring; ring Xis a heterocyclic ring as defined in the specification; A is phenylene or 5-7C cycloalkylene, or a 1-8C alkylene into which is optionally inserted one or two groups; and R3 and R4 are a variety of radicals described in the specification: and the pharmaceutically-acceptable acid-addition salts thereof. Manufacturing processes and pharmaceutical compositions are also described.
398640
Jones Derrick F.
Oldham Keith
Imperial Chemical Industries Plc
Smart & Biggar
LandOfFree
Heterocyclic derivatives as histamine h-2 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic derivatives as histamine h-2 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as histamine h-2 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1208340